Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis

被引:82
作者
Kamata, Koichi
Kamijo, Seiji
Nakajima, Atsuo
Koyanagi, Akemi
Kurosawa, Hisashi
Yagita, Hideo
Okumura, Ko
机构
[1] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Juntendo Univ, Sch Med, Dept Orthopaed, Tokyo 1138421, Japan
[3] Juntendo Univ, Sch Med, Div Cell Biol, Tokyo 1138421, Japan
[4] Nippon Med Coll, Dept Joint Dis & Rheumatism, Tokyo 113, Japan
关键词
TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; FACTOR-ALPHA; MONOCLONAL-ANTIBODIES; SYNOVIAL FIBROBLASTS; AUTOIMMUNE-DISEASE; ENDOTHELIAL-CELLS; FACTOR RECEPTOR; GROWTH-FACTOR; T-CELLS;
D O I
10.4049/jimmunol.177.9.6433
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
TNF-like weak inducer of apoptosis (TWEAK) is a type 11 membrane protein belonging to the TNF family that regulates apoptotic cell death, cellular proliferation, angiogenesis, and inflammation. However, the role of TWEAK in the pathogenesis of rheumatoid arthritis (RA) remains unclear. In this study, we have investigated the effect of neutralizing anti-TWEAK mAb on the development of collagen-induced arthritis (CIA), a well-established murine model of RA. Administration of anti-TWEAK mAb significantly ameliorated paw swelling, synovial hyperplasia, and infiltration of inflammatory cells. The levels of proinflammatory ehemokines such as MCP-1 and MIP-2 in serum and knee joints were reduced by this treatment. Consistently, recombinant TWEAK enhanced the proliferation of MCP-1 and MIP-2 production by synovial cells from CIA mice in vitro. Histological examination also revealed that the treatment with anti-TWEAK mAb suppressed the development of small vessels in synovial tissues. These results indicated anti-inflammatory and antiangiogenic effects of the TWEAK blockade in CIA, which may be also beneficial for the treatment of RA.
引用
收藏
页码:6433 / 6439
页数:7
相关论文
共 51 条
  • [1] Brennan FM, 1997, BRIT J RHEUMATOL, V36, P643
  • [2] Charles P, 1999, J IMMUNOL, V163, P1521
  • [3] TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis
    Chicheportiche, Y
    Bourdon, PR
    Xu, HD
    Hsu, YM
    Scott, H
    Hession, C
    Garcia, I
    Browning, JL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) : 32401 - 32410
  • [4] Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies
    Chicheportiche, Y
    Chicheportiche, R
    Sizing, I
    Thompson, J
    Benjamin, CB
    Ambrose, C
    Dayer, JM
    [J]. ARTHRITIS RESEARCH, 2002, 4 (02) : 126 - 133
  • [5] Down-regulated expression of TWEAK mRNA in acute and chronic inflammatory pathologies
    Chicheportiche, Y
    Fossati-Jimack, L
    Moll, S
    Ibnou-Zekri, N
    Izui, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (01) : 162 - 165
  • [6] Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis
    Cook, AD
    Braine, EL
    Campbell, IK
    Hamilton, JA
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (03) : 917 - 926
  • [7] Anti-TNFα therapy of rheumatoid arthritis:: what have we learned?
    Feldmann, M
    Maini, RN
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 : 163 - 196
  • [8] Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells
    Harada, N
    Nakayama, M
    Nakano, H
    Fukuchi, Y
    Yagita, H
    Okumura, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 299 (03) : 488 - 493
  • [9] REGULATION OF TRANSENDOTHELIAL NEUTROPHIL MIGRATION BY ENDOGENOUS INTERLEUKIN-8
    HUBER, AR
    KUNKEL, SL
    TODD, RF
    WEISS, SJ
    [J]. SCIENCE, 1991, 254 (5028) : 99 - 102
  • [10] TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis
    Ichikawa, K
    Liu, WM
    Fleck, M
    Zhang, HG
    Zhao, LM
    Ohtsuka, T
    Wang, Z
    Liu, D
    Mountz, JD
    Ohtsuki, M
    Koopman, WJ
    Kimberly, R
    Zhou, T
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (02) : 1061 - 1069